Augmented macrophage differentiation and polarization of tumor-associated macrophages towards m1 subtype in listeria-administered tumor-bearing host

Journal of Immunotherapy

Volumn 35, Issue 7, 2012, Pages 544-554

  Rai, Rakesh K ^a   Vishvakarma, Naveen K ^b   Mohapatra, Tribhuban M ^a   Singh, Sukh Mahendra ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Listeria; myelopoiesis; tumor microenvironment; tumor progression; tumor associated macrophages

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; L SELECTIN; MONOCARBOXYLATE TRANSPORTER 1; NITRIC OXIDE; PROTEIN P53; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FUNCTIONAL STATUS; LISTERIA; LISTERIOSIS; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INFLAMMATION MEDIATORS; LISTERIA; LISTERIOSIS; LYMPHOMA, T-CELL; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MONOCARBOXYLIC ACID TRANSPORTERS; NITRIC OXIDE; PHAGOCYTOSIS; SYMPORTERS;

EID: 84865529572     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3182661afa     Document Type: Article

References (42)

1. Linnebacher M, Maletzki C, Klier U, et al. Bacterial immunotherapy of gastrointestinal tumors. Langenbecks Arch Surg. 2011;397:557-568.
2. Olino K, Wada S, Edil BH, et al. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases. Ann Surg Oncol. 2011. In Press. DOI: 10.1245/s10434-011-2037-0.
3. Roider E, Jellbauer S, Koehn B, et al. Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer. Cancer Immunol Immunother. 2011;60:371-380.
4. Guirnalda P, Wood L, Paterson Y. Listeria monocytogenes and its products as agents for cancer immunotherapy. Adv Immunol. 2012;113:81-118.
5. Singh R, Wallecha A. Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic. Hum Vaccin. 2011;7:497-505.
6. Skoberne M, Yewdall A, Bahjat KS, et al. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. J Clin Invest. 2008;118:3990-4001.
7. Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol. 2012;167:195-205.
8. Porta C, Riboldi E, Totaro MG, et al. Macrophages in cancer and infectious diseases: the "good" and the "bad". Immunotherapy. 2011;3:1185-1202.
9. Hardy J, Chu P, Contag CH. Foci of Listeria monocytogenes persist in the bone marrow. Dis Model Mech. 2009;2:39-46.
10. Cortez-Retamozo V, Etzrodt M, Newton A, et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA. 2012;109:2491-2496.
11. Bharti AC, Singh SM. Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol Lett. 2000;72:39-48. (Pubitemid 30160708)
12. Bharti AC, Singh SM. Inhibition of macrophage nitric oxide production by gangliosides derived from a spontaneous T cell lymphoma: the involved mechanisms. Nitric Oxide. 2003;8:75-82. (Pubitemid 36263435)
13. Singh V, Singh SM. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs. 2007;18:1123-1132. (Pubitemid 47480737)
14. Singh V, Singh MP, Singh SM. Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Anticancer Drugs. 2008;19:793-804.
15. Gupta V, Singh SM. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells. Am J Reprod Immunol. 2008;60:43-54. (Pubitemid 351844099)
16. Verma VK, Singh V, Singh MP, et al. Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: implications in exercise-dependent tumor growth retardation. Immunopharmacol Immunotoxicol. 2009;31:274-282.
17. Vishvakarma NK, Singh SM. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: implication in antitumor activation of tumorassociated macrophages. Immunol Lett. 2010;134:83-92.
18. Vishvakarma NK, Singh SM. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole. Biochimie. 2011;93:1786-1796.
19. Vishvakarma NK, Singh SM. Mechanisms of tumor growth retardation by modulation of pH regulation in the tumormicroenvironment of a murine T cell lymphoma. Biomed Pharmacother. 2011;65:27-39.
20. Vishvakarma NK, Kumar A, Singh SM. Role of curcumindependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival. Toxicol Appl Pharmacol. 2011;252:298-306.
21. Singh N, Singh SM, Prakash, et al. Restoration of thymic homeostasis in a tumor-bearing host by in vivo administration of medicinal herb Tinosporacordifolia. Immunopharmacol Immunotoxicol. 2005;27:585-599. (Pubitemid 43220926)
22. Shrivastava P, Singh SM, Singh N. Activation of tumorassociated macrophages by thymosin alpha 1. Int J Immunopathol Pharmacol. 2005;17:39-47.
23. Kumar A, Vishvakarma NK, Bharti A, et al. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host. Blood Cells Mol Dis. 2012;48:137-144.
24. Kumar A, Vishvakarma NK, Tyagi A, et al. Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival. Biosci Rep. 2012;32:91-104.
25. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008. doi: 10.1101/pdb.prot5080.
26. ChapnickDA, Warner L, Bernet J, et al. Partners in crime: TGFbeta and MAPK pathways in cancer progression. Cell Biosci. 2011;1:42.
27. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007; 117:1175-1183. (Pubitemid 46718402)
28. Li P, Du Q, Cao Z, et al. Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Lett. 2012;314:213-222.
29. Bashyam H. IFN gamma: issuing macrophages a license to kill. J Exp Med. 2007;204:3.
30. Tham SM, Ng KH, Pook SH, et al. Tumor and microenvironment modification during progression of murine orthotopic bladder cancer. Clin Dev Immunol. 2011;2011:865684.
31. Rieger AM, Hall BE, Barreda DR. Macrophage activation differentially modulates particle binding, phagocytosis and downstream antimicrobial mechanisms. Dev Comp Immunol. 2010;34:1144-1159.
32. Stewart TJ, Smyth MJ. Improving cancer immunotherapy by targeting tumor-induced immune suppression. Cancer Metastasis Rev. 2011;30:125-140.
33. Moreau A, Le Vee M, Jouan E, et al. Drug transporter expression in human macrophages. Fundam Clin Pharmacol. 2011;25:743-752.
34. Samuvel DJ, Sundararaj KP, Nareika A, et al. Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol. 2009;182:2476-2484.
35. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol. 2002;20:825-852. (Pubitemid 34293441)
36. Vance RE. Inflammasome activation: how macrophages watch what they eat. Cell Host Microbe. 2010;7:3-5.
37. Mosa A, Trumstedt C, Eriksson E, et al. Nonhematopoietic cells control the outcome of infection with Listeria monocytogenes in a nucleotide oligomerization domain 1-dependent manner. Infect Immun. 2009;77:2908-2918.
38. Torello CO, de Souza Queiroz J, Oliveira SC, et al. Immunohematopoietic modulation by oral b-1,3-glucan in mice infected with Listeria monocytogenes. Int Immunopharmacol. 2010;10:1573-1579.
39. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007;117:1155-1166. (Pubitemid 46718400)
40. Metcalf D. Hematopoietic cytokines. Blood. 2008;111:485-491.
41. Rodrguez Mdel C, Bernad A, Aracil M. Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood. 2004;103:3349-3354. (Pubitemid 38525663)
42. MacNamara KC, Oduro K, Martin O, et al. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-g signaling. J Immunol. 2011;186: 1032-1043.